Imiquimod
Product Images NDC 54868-6179

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Imiquimod (NDC 54868-6179). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Physicians Total Care, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Imi00 0004 01)

Structural Formula (Imi00 0004 01)
Chemical structure of Imiquimod showing its fused ring system with attached amino and isobutyl side groups.*
FDA Label Image

Figure 1 (Imi00 0004 02)

Figure 1 (Imi00 0004 02)
A flowchart depicting participant distribution and treatment outcomes in a study comparing Imiquimod Cream and Vehicle. It shows the number enrolled, withdrawals, treatment completion, and clarity status at 16 weeks, along with follow-up results for those who cleared at 12 weeks. The chart illustrates progression and attrition over the treatment and follow-up periods.*
FDA Label Image

Package Label – Principal Display Panel – Carrier For 24 Single-use Foilpacs® (Package Label)

Package Label – Principal Display Panel – Carrier For 24 Single-use Foilpacs® (Package Label)
Label for Imiquimod 5% Cream distributed by Physicians Total Care, Inc. in Tulsa, OK. It shows the product NDC 54868-6179-0, lot number 0000, and an expiration date of 01/60. The label also includes a barcode and manufacturer information for F. Hoffmann-La Roche Ltd in Melville, NY.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.